These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13406265)

  • 1. Effects of ultraviolet light on poliomyelitis virus.
    TAYLOR AR; KAY WW; MCLEAN IW; OPPENHEIMER F; STIMPERT FD
    J Immunol; 1957 Jan; 78(1):45-55. PubMed ID: 13406265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inactivation of poliomyelitis virus by ultraviolet rays using a series apparatus. Comparison with bacteriologic results].
    Maurin J; Escallier G
    Bull Acad Natl Med; 1968; 152(23):377-89. PubMed ID: 4313650
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultraviolet light inactivation of poliomyelitis virus.
    FOGH J
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):464-5. PubMed ID: 13254795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of radium on the radium on the poliomyelitis virus].
    LACORTE JG; MONTEIRO E; LOURES JC
    Mem Inst Oswaldo Cruz; 1959 Oct; 57():83-91. PubMed ID: 14413329
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulsed UV-light inactivation of poliovirus and adenovirus.
    Lamont Y; Rzezutka A; Anderson JG; MacGregor SJ; Given MJ; Deppe C; Cook N
    Lett Appl Microbiol; 2007 Nov; 45(5):564-7. PubMed ID: 17944833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of x-irradiation on the yield of poliovirus.
    LEVINE S
    Virology; 1960 Feb; 10():257-67. PubMed ID: 14416296
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunochemical studies of poliovirus. IV. Alteration of the immunologic specificity of purified poliomyelitis virus by heat and ultraviolet light.
    ROIZMAN B; MAYER MM; ROANE PR
    J Immunol; 1959 Jan; 82(1):19-25. PubMed ID: 13620911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of poliomyelitis virus after ionising radiation].
    Lacorte JG; Monteiro E; Loures JC
    Mem Inst Oswaldo Cruz; 1971; 69(3):501-21. PubMed ID: 4335058
    [No Abstract]   [Full Text] [Related]  

  • 9. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis.
    Kindberg E; Ax C; Fiore L; Svensson L
    J Med Virol; 2009 May; 81(5):933-6. PubMed ID: 19319949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
    Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of non-paralytic poliomyelitis and a clinical comparison of poliomyelitis epidemics due to type I and type II virus.
    FORBES JA
    Med J Aust; 1955 May; 42(1 20):719-20. PubMed ID: 14382886
    [No Abstract]   [Full Text] [Related]  

  • 15. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event.
    Mueller S; Wimmer E; Cello J
    Virus Res; 2005 Aug; 111(2):175-93. PubMed ID: 15885840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Poliomyelitis in Campania in 1956; incidence of the three types of poliomyelitis virus as causative agents of paralytic poliomyelitis].
    SALVAGGIO L; ALBANO A
    Boll Ist Sieroter Milan; 1958; 37(7-8):339-45. PubMed ID: 13584528
    [No Abstract]   [Full Text] [Related]  

  • 18. [Papillitis and neutralization reactions to poliomyelitis virus].
    RENARD G; SARAUX H; GORINS A; CAILLE B
    Bull Soc Ophtalmol Fr; 1962 Feb; 62():124-8. PubMed ID: 13981621
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].
    Blondel B; Autret A; Brisac C; Pelletier I; Martin-Latil S; Jegouic S; Bessaud M; Joffret ML; Balanant J; Colbère-Garapin F; Delpeyroux F
    Med Trop (Mars); 2008 Apr; 68(2):189-202. PubMed ID: 18630055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.